Objectives: The goal of this study was to develop a risk score model for patients with Brugada syndrome (BrS). Background: Risk stratification in BrS is a significant challenge due to the low event rates and conflicting evidence. Methods: A multicenter international cohort of patients with BrS and no previous cardiac arrest was used to evaluate the role of 16 proposed clinical or electrocardiogram (ECG) markers in predicting ventricular arrhythmias (VAs)/sudden cardiac death (SCD) during follow-up. Predictive markers were incorporated into a risk score model, and this model was validated by using out-of-sample cross-validation. Results: A total of 1,110 patients with BrS from 16 centers in 8 countries were included (mean age 51.8 ± 13.6 years; 71.8% male). Median follow-up was 5.33 years; 114 patients had VA/SCD (10.3%) with an annual event rate of 1.5%. Of the 16 proposed risk factors, probable arrhythmia–related syncope (hazard ratio [HR]: 3.71; p < 0.001), spontaneous type 1 ECG (HR: 3.80; p < 0.001), early repolarization (HR: 3.42; p < 0.001), and a type 1 Brugada ECG pattern in peripheral leads (HR: 2.33; p < 0.001) were associated with a higher risk of VA/SCD. A risk score model incorporating these factors revealed a sensitivity of 71.2% (95% confidence interval: 61.5 to 84.6) and a specificity of 80.2% (95% confidence interval: 75.7 to 82.3) in predicting VA/SCD at 5 years. Calibration plots showed a mean prediction error of 1.2%. The model was effectively validated by using out-of-sample cross-validation according to country. Conclusions: This multicenter study identified 4 risk factors for VA/SCD in a primary prevention BrS population. A risk score model was generated to quantify risk of VA/SCD in BrS and inform implantable cardioverter-defibrillator prescription.

Honarbakhsh, S., Providencia, R., Garcia-Hernandez, J., Martin, C., Hunter, R., Lim, W., et al. (2021). A Primary Prevention Clinical Risk Score Model for Patients With Brugada Syndrome (BRUGADA-RISK). JACC. CLINICAL ELECTROPHYSIOLOGY, 7(2 (February 2021)), 210-222 [10.1016/j.jacep.2020.08.032].

A Primary Prevention Clinical Risk Score Model for Patients With Brugada Syndrome (BRUGADA-RISK)

Crotti L.;
2021

Abstract

Objectives: The goal of this study was to develop a risk score model for patients with Brugada syndrome (BrS). Background: Risk stratification in BrS is a significant challenge due to the low event rates and conflicting evidence. Methods: A multicenter international cohort of patients with BrS and no previous cardiac arrest was used to evaluate the role of 16 proposed clinical or electrocardiogram (ECG) markers in predicting ventricular arrhythmias (VAs)/sudden cardiac death (SCD) during follow-up. Predictive markers were incorporated into a risk score model, and this model was validated by using out-of-sample cross-validation. Results: A total of 1,110 patients with BrS from 16 centers in 8 countries were included (mean age 51.8 ± 13.6 years; 71.8% male). Median follow-up was 5.33 years; 114 patients had VA/SCD (10.3%) with an annual event rate of 1.5%. Of the 16 proposed risk factors, probable arrhythmia–related syncope (hazard ratio [HR]: 3.71; p < 0.001), spontaneous type 1 ECG (HR: 3.80; p < 0.001), early repolarization (HR: 3.42; p < 0.001), and a type 1 Brugada ECG pattern in peripheral leads (HR: 2.33; p < 0.001) were associated with a higher risk of VA/SCD. A risk score model incorporating these factors revealed a sensitivity of 71.2% (95% confidence interval: 61.5 to 84.6) and a specificity of 80.2% (95% confidence interval: 75.7 to 82.3) in predicting VA/SCD at 5 years. Calibration plots showed a mean prediction error of 1.2%. The model was effectively validated by using out-of-sample cross-validation according to country. Conclusions: This multicenter study identified 4 risk factors for VA/SCD in a primary prevention BrS population. A risk score model was generated to quantify risk of VA/SCD in BrS and inform implantable cardioverter-defibrillator prescription.
Si
Articolo in rivista - Articolo scientifico
Scientifica
Brugada syndrome; inherited channelopathy; sudden cardiac death; ventricular arrhythmia;
English
Honarbakhsh, S., Providencia, R., Garcia-Hernandez, J., Martin, C., Hunter, R., Lim, W., et al. (2021). A Primary Prevention Clinical Risk Score Model for Patients With Brugada Syndrome (BRUGADA-RISK). JACC. CLINICAL ELECTROPHYSIOLOGY, 7(2 (February 2021)), 210-222 [10.1016/j.jacep.2020.08.032].
Honarbakhsh, S; Providencia, R; Garcia-Hernandez, J; Martin, C; Hunter, R; Lim, W; Kirkby, C; Graham, A; Sharifzadehgan, A; Waldmann, V; Marijon, E; Munoz-Esparza, C; Lacunza, J; Gimeno-Blanes, J; Ankou, B; Chevalier, P; Antonio, N; Elvas, L; Castelletti, S; Crotti, L; Schwartz, P; Scanavacca, M; Darrieux, F; Sacilotto, L; Mueller-Leisse, J; Veltmann, C; Vicentini, A; Demarchi, A; Cortez-Dias, N; Antonio, P; de Sousa, J; Adragao, P; Cavaco, D; Costa, F; Khoueiry, Z; Boveda, S; Sousa, M; Jebberi, Z; Heck, P; Mehta, S; Conte, G; Ozkartal, T; Auricchio, A; Lowe, M; Schilling, R; Prieto-Merino, D; Lambiase, P
File in questo prodotto:
File Dimensione Formato  
Honarbakhsh 2020.pdf

Solo gestori archivio

Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Dimensione 2.3 MB
Formato Adobe PDF
2.3 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10281/299002
Citazioni
  • Scopus 12
  • ???jsp.display-item.citation.isi??? 12
Social impact